Pediatric Clinical Trial Program in Progress: A Phase 3 Study and Long-term Extension Study to Evaluate the Efficacy and Safety of Ritlecitinib in Children 6 to <12 years of Age With Severe Alopecia Areata. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s768, 2026. DOI: 10.25251/bqftmw67. Disponível em: https://skin.dermsquared.com/skin/article/view/4047. Acesso em: 30 apr. 2026.